A puzzle piece with a stick figure.

Patrick Genestin to lead Hikma's generics business development

Genestin previously served as vice president of business development and licensing, and mergers and acquisitions for the U.S. entity of Sandoz.
Sandra Levy
Senior Editor
Sandra Levy profile picture

Hikma is welcoming a new executive to lead its generics business development. Patrick Genestin is joining the company as vice president of business development and generics.

Genestin has more than 25 years of experience in the pharmaceutical industry as a results-driven executive with strong financial, business development, and mergers and acquisitions experience, the company said. He will be based at the company’s U.S. headquarters in Berkeley Heights, N.J.

In this role, Genestin is responsible for driving pipeline strategy and identifying new growth opportunities for Hikma’s generics business, including leading the execution of licensing and M&A deals, proactively identifying business development opportunities, and maintaining and growing Hikma’s contract manufacturing business.

"Patrick is an established business development leader whose extensive industry experience will be critical to Hikma as we build on our successful track record," said Brian Hoffmann, president, Hikma Generics. "His expertise will be instrumental in helping us to develop new partnerships and acquire new products that will bolster our differentiated pipeline. He will also work to leverage our state-of-the-art Columbus, Ohio manufacturing facility by identifying new contract manufacturing opportunities, and will explore new growth areas including commercializing our portfolio outside of the United States.”

“I am excited to be joining Hikma at an important time for the company and the Generics business,” said Genestin. “With its strong manufacturing capabilities and outstanding facilities, excellent quality record, and proven ability to commercialize, Hikma’s Generics business has long been seen as a partner of choice in the industry. I look forward to working together with Hikma’s excellent team to build on this position of strength, lead our pipeline strategy, help deliver continued growth and ensure that important generic medicines continue to be made available to the patients who rely on them.”

Prior to joining Hikma, Genestin served as vice president of business development and licensing and M&A for the U.S. entity of Sandoz.

A native of France, Genestin received his bachelor's degree from L’Ecole Superieure de Commerce de Nantes and holds an M.B.A. in finance from Penn State University.